Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone (DHT). It is known for its distinctive anabolic and androgenic properties, with no significant estrogenic activity. Unlike testosterone-based compounds, Stanozolol does not aromatize into estrogen. Its pharmacological profile is associated with increased nitrogen retention, changes in protein metabolism, and effects on muscle composition. It has also been studied for its influence on collagen synthesis and certain blood lipid parameters. Its use carries significant health risks, including adverse effects on liver function, cholesterol levels, and cardiovascular health. Injectable administration does not eliminate these risks.